Rocket One Inc. RKTO
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-02-15
Rocket One Inc. financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| R&D expense | $5.9M | $3.2M | $3.7M | $4.9M | $7.4M | $2.3M | $2.0M | $785,274 |
| Operating income | -$12.4M | -$8.2M | -$8.0M | -$11.1M | -$14.1M | -$7.3M | -$7.7M | -$2.5M |
| Net income | -$12.5M | -$8.2M | -$8.1M | -$11.4M | -$14.3M | -$7.2M | -$7.7M | -$2.5M |
| EPS (diluted) | $-0.90 | $-1.28 | $-2.38 | $-9.50 | $-16.02 | — | — | — |
| Operating cash flow | -$9.8M | -$7.0M | -$8.4M | -$9.3M | -$12.1M | -$6.1M | -$4.9M | -$2.1M |
| Cash & equivalents | $6.2M | $7.0M | $9.3M | $6.4M | $8.5M | $2.6M | $1.7M | $282,621 |
| Total assets | $7.6M | $7.7M | $10.2M | $7.7M | $11.0M | $5.2M | $2.8M | $503,916 |
| Total liabilities | $1.5M | $833,906 | $704,983 | $1.6M | $1.1M | $597,149 | $440,121 | $348,951 |
| Shareholders' equity | $6.2M | $6.9M | $9.5M | $6.1M | $9.9M | $4.6M | $2.4M | $154,965 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.